Literature DB >> 4264577

Observations on the dopaminergic nature of hyperthyroid chorea.

H L Klawans, D M Shenker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4264577     DOI: 10.1007/bf01244729

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  20 in total

1.  On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors:  N E ANDEN; B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1963-07

2.  [EXPERIENCES WITH L-DOPA IN THE THERAPY OF PARKINSONISM].

Authors:  F GERSTENBRAND; K PATEISKY; P PROSENZ
Journal:  Psychiatr Neurol (Basel)       Date:  1963

3.  The pharmacology of Rauwolfia.

Authors:  H J BEIN
Journal:  Pharmacol Rev       Date:  1956-09       Impact factor: 25.468

4.  [A Rauwolfia alkaloid in psychiatry: similarity of its effects to those of chloropromazine].

Authors:  E WEBER
Journal:  Schweiz Med Wochenschr       Date:  1954-08-21

5.  Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat.

Authors:  B E Roos
Journal:  J Pharm Pharmacol       Date:  1969-04       Impact factor: 3.765

6.  A pharmacologic analysis of Huntington's chorea.

Authors:  H L Klawans
Journal:  Eur Neurol       Date:  1970       Impact factor: 1.710

7.  Cerebrospinal fluid homovanillic acid in Huntington's chorea.

Authors:  H L Klawans
Journal:  J Neurol Sci       Date:  1971-07       Impact factor: 3.181

8.  Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine.

Authors:  H Nybäck; G Sedvall
Journal:  Eur J Pharmacol       Date:  1969-02       Impact factor: 4.432

9.  Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans.

Authors:  A Pletscher; G Bartholini; R Tissot
Journal:  Brain Res       Date:  1967-02       Impact factor: 3.252

10.  On the origin of homovanillic acid in the cerebrospinal fluid.

Authors:  G Bartholini; A Pletscher; R Tissot
Journal:  Experientia       Date:  1966-09-15
View more
  10 in total

1.  Graves' disease presenting as hemiparkinsonism.

Authors:  J S Davies; P K Morrish; M F Scanlon
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

2.  Localization of triiodothyronine in nerve ending fractions of rat brain.

Authors:  M B Dratman; F L Crutchfield; J Axelrod; R W Colburn; N Thoa
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

3.  Persistent chorea as a manifestation of thyrotoxicosis.

Authors:  A Javaid; D D Hilton
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

4.  Dopamine receptor site sensitivity in hyperthyroid guinea pigs: a possible model of hyperthyroid chorea.

Authors:  H L Klawans; C H Goetz; W J Weiner
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

Review 5.  On the role of dopamine in the pathophysiology of anorexia nervosa.

Authors:  V C Barry; H L Klawans
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

6.  Serum dopamine-beta-hydroxylase activity: clinical applications in child psychiatry.

Authors:  J G Young; R M Kyprie; N T Ross; D J Cohen
Journal:  J Autism Dev Disord       Date:  1980-03

7.  Thyroid hormone in autistic children.

Authors:  D J Cohen; J G Young; T L Lowe; D Harcherik
Journal:  J Autism Dev Disord       Date:  1980-12

Review 8.  Dystonia and chorea in acquired systemic disorders.

Authors:  J L Janavs; M J Aminoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

9.  Commentary.

Authors:  Murat Alemdar
Journal:  J Neurosci Rural Pract       Date:  2013-10

10.  Anti-Thyroid Peroxidase/Anti-Thyroglobulin Antibody-Related Neurologic Disorder Responsive to Steroids Presenting with Pure Acute Onset Chorea.

Authors:  Ritwik Ghosh; Subhankar Chatterjee; Souvik Dubey; Alak Pandit; Biman Kanti Ray; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-07-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.